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Summary.-The results of a series of mouse-skin paintings are given for fractions
prepared by two schemes designed to concentrate the polycyclic aromatic hydro-
carbons (PAH) and their heterocyclic analogues (HETC) present in cigarette smoke
condensate into single fractions. It is demonstrated that, for each group, a single
index of tumour response, the " Weibull risk parameter " (WRP), can be calculated
which, considered in conjunction with two other parameters common to all the groups,
adequately describes the pattern of tumour incidence in that group. These indices
can be used to calculate for each fraction a further statistic, the " tumorigenic ratio "
(TR), which conveniently measures the activity of the fraction relative to whole-
smoke condensate on a weight-for-weight basis. From the analyses it is shown that
the separation processes can successfully concentrate all types of mouse-skin carcino-
genic material, irrespective of the type of condensate used, and that a combination of
processes prepares an active concentrate representing 2% by weight of the original
condensate.
THE complete carcinogenis for mouse
skin (substances which produce skin
tumours when tested alone) that have
been chemically identified in cigarette
smoke fall into two chemically related
groups: the polveyclic aromatic hydro-
carbons (PAH) and their heterocyclic
analogues (HETC) in particular the N-
heterocyclic compounds (Wvnder and
Hoffman, 1959, 1968; Hoffmann and
Wynder, 1966). Wlhitehead and Rothwell
(1969) described a number of solvent
partition methods in which the PAH and
HETC constituents of smoke could be
concentrated into single fractions. They
showed that virtually all the carcinogenic
components of whole-smoke condensate
are insoluble in water (Fraction C) and can
substantially be extracted from aqueous
methanol solution by cyclohexane. This
cyclohexane fraction (Fraction (G, Figs. 1
and 2) has been used as the starting
material for attempts to isolate further
the components of smoke condensate
carcinogenic to mouse skin. This paper
gives the results of mouse skin bioassays
of fractions prepared from Fraction G(
using two bilateral solvent-distribution
procedures.
The first procedure (XVhitehead and
Rothwell, 1]969) used the solvent pair
cyclohexane and dimethyl sulphoxide,
resulting in the fractions K(G) and L(G).
The second procedure was based on work
by Rothwell and WThitehead (1969), who
showed that many N-heterocyclic
aromatic substances could be extracted
from cyclohexane solution by aqueous
formic acid (90%0 w/v). This procedure
resulted in two fractions; R(G), which
contains basic heterocyclic compounds
together with other formic-acid-soluble
substances, and P(G), which contains all
the PAH of Fraction G, together with
Address for reprints. The Librarian, Tobacco Research Council, Gleni Houise, Stag Place, London
S-WIE 5AG.
Present addresses. * Tobacco Research Cotutncil, Glen Hotuse, Stag Place, LoIIdoIn SWIE 5AG. t 45
Aspin Park Road, Knaresborough, Yorkshire.
I Now Hazleton Laboratories Eur()pe Lirnited.FRACTIONATION OF CARCINOGENS IN CIGARETTE SMOKE
A. Whole smoke condensate (SWS)
100% w/w
Wa
B. Water-soluble fraction
52-0% w/w
F. Aq. meth
15-1°
K(G).
~ter
C.Water soluble fraction
45*3% w/w
Aq. MeOH/cyclohexane
ianol fraction G. Cyclohexane fraction
50 w/w 24-5% w/w
Cyclohexane/dimethyl sulphoxide
(DMSO)
Cyclohexane extract L(G). DMSO extract
15-0%w/w 7-5% w/w
FIG. 1.-Methods of concentration of mouse skin carcinogens of whole smoke condensate (Scheme 1)
other substances which form complexes
with caffeine.
MATERIALS AND METHODS
Preparation of condensates
Cigars (Cl, C3).-Two batches of small
cigars (each of length 83 mm, circumference
33-7 mm and weight 1 86 g) were specially
manufactured from composite blends of cigar
tobacco representing small-cigar brands
smoked in the United Kingdom shortly before
the relevant experiments. The filler was
granulated tobacco and the wrapper and
binder natural leaf. Cigars were wrapped
individually in cellophane and packed in
batches of 5 in cardboard cartons which were
also wrapped in cellophane and stored at
21°C and controlled humidity of 60% RH
before use.
Standard flue-cured cigarettes (T4, T24,
T29, T44, T57).-Five batches of plain
cigarettes (each of about length 70 mm,
circumference 25-3 mm and weight 1 09 g)
were specially manufactured from composite
blends of flue-cured tobacco, representing the
major plain cigarette brands smoked in the
United Kingdom shortly before the various
experiments. Cigarettes were packed in
batches of 50 in vacuum-sealed tins and
stored at 4°C before use.
Nitrate-treated cigarettes (T22, T56).-Two
batches of plain cigarettes (each of length
70 mm, circumference 25 3 mm, weight 1.18g)
were specially manufactured from a com-
posite blend of flue-cured tobacco, as for the
standard cigarettes above, but treated with
3% w/w sodium nitrate, and were packed and
stored in the same way.
Smoking procedures.-The automatic
smoking machine described by Day (1967)
was used for smoking all these products, a
separate smoking disc furnished with appro-
priately sized holders being fitted for cigar
smoking. The same smoking parameters were
used as given by Davies and Day (1969).
Non-volatile whole smoke condensate
(NVWSC).-Whole smoke condensate was
collected, checked for non-volatile whole
smoke yield by determination ofnicotine, and
the solvent evaporated for the preparation of
NVWSC, using the methods described by
Davies and Day (1969).
Stored condensate (SWS).-NVWSC col-
lected over 4 weeks was combined and stored
at -29°C for a further 4 weeks before use.
Solvents.-All solvents were purified by
the method described by Whitehead and
Rothwell (1969).
Preparation offractions
Fractionation Scheme 1 (Fig. 1; after
Whitehead and Rothwell, 1969)
Stages 1 and 2. Fractions B, C, F and G
were prepared from SWS by removal of the
water-soluble materials (Fraction B) and
subsequent distribution of the water-soluble
residue (Fraction C) between 90% v/v
aqueous methanol (Fraction F) and cyclo-
hexane (Fraction G).
Stage 1
Stage 2
Stage 3
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Stage 3. Fractions K(G) and L(G) were
prepared by distribution of Fraction G
between cyclohexane (Fraction K(G)) and
dimethyl sulphoxide (Fraction L(G)).
Fractionation Scheme 2 (Fig. 2; after
Rothwell and Whitehead, 1969)
Stages 1 and 2. Fractions B, C, F and G
were prepared as in Scheme 1.
Stage 3 (Scheme 2a) Fractions Q(G) and
(R + P)G. Fraction G (10 g) dissolved in
cyclohexane (100 ml) was extracted 8 x with
a solution of caffeine (15% w/v) in aqueous
90% formic acid (8 x 30 ml). The cyclo-
hexane phase was washed with water
(2 x 30 ml) and Fraction Q(G) was
recovered by evaporation ofthe solvent. The
formic acid phase was diluted to 2 1 with
water, extracted with benzene (3 x 100 ml),
neutralized with caustic soda, and again
extracted with benzene (3 x 100 ml). Frac-
tion (R + P)G remained after washing the
benzene extracts and removing the solvent
under reduced pressure.
Stage 3 (Scheme 2b) Fractions R(G) and
S(G). Fraction G (10 g) dissolved in cyclo-
hexane (100 ml) was extracted 4 x with
aqueous 90% formic acid (50; 30; 20; 20 ml).
The cyclohexane phase was washed with
water (2 x 30 ml) and Fraction S(G) was
recovered by evaporation of the solvent.
Fraction R(G) was recovered from the formic
acid phase by dilution, neutralization and
benzene extraction as detailed above for
(R + P)G.
Stage 4 (Scheme 2b) Fractions P(SG) and
Q(SG). Fraction S(G) (from 10 g G) dissolved
in cyclohexane (100 ml) was extracted 8 x
with a solution of caffeine (15% w/v) in
aqueous 90% formic acid (8 X 20 ml). Frac-
tion Q(SG) was isolated from the cyclohexane
phase, and P(SG) was isolated from the
formic acid phase, by the methods described
above.
Mouse skin bioassays
Mice.-Ten batches of female albino mice
of a specific-pathogen-free strain were
obtained over a 6-year period from the
Pharmaceuticals Division, Imperial Chemical
Industries Ltd. (Exps. 1-5) or from Carworth
Europe Ltd, Huntingdon (Exps. 6-10) at 4-6
weeks of age.
Details of treatment.-The mice from each
experiment were randomly allocated to treat-
ments, the 10 experiments involving a total of
55 treatments as detailed in Tables JI-VIII.
The date treatment started, the age at first
treatment and the duration of treatment for
each experiment are given in Table I.
Doses.-All doses of test material are
expressed in terms of NVWSC equivalent
weights mg/wk (equivalent dose), i.e. in the
case offractions the amount ofSWS required
to yield the actual amount offractions applied
per week per mouse.
Method and frequency of application.-In
the case ofExp. 1, the mice were sub-divided
into 4 painting regimes known as 2, 3S, 3F
and 31. On Regime 2, applications were
made twice weekly on Tuesday and Friday,
on 3S, thrice weekly on Monday, Wednesday
and Friday, on 3F, thrice weekly on Tuesday,
Wednesday and Friday, and on 32, every
alternate day (including weekends). In all
other experiments, all mice were painted
under Regime 3S. Each application was
made by means of an automatic pipette in a
uniform volume of 0 3 ml of the appropriate
solvent, spread over the whole back of the
mouse after it had been shaved.
TABLE I.-Starting Date, Age of Mice and Duration of Treatmentfor each
Experiment
Experiment Starting
number date
1 Feb. 1966
2 Nov. 1966
3 Feb. 1967
4 Nov. 1967
5 Feb. 1968
6 Feb. 1969
7 Mar. 1969
8 Apr. 1969
9 Aug. 1970
10 June 1971
* See Table VI.
t See Tables III and IV.
Age at first
treatment (wks)
12
11
13
9
9
9
10
10
9
10
Duration of
treatment
Life
Life
93 wks
Life
Life
Life
Life
56 or 60 wks*
Life or 80 wkst
Life
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Solvents.-Exps. 1, 3, 8 and 9, all the
smoke condensates and fractions were dis-
solved in acetone-water: 9/1. In Exps. 4, 5,
6, 7 and 10, the solvent used was acetone-
isopropanol: 4/1. In Exp. 2 the smoke con-
densate tested was dissolved in acetone-
water: 9/1 and the fraction tested, G, in
acetone-petroleum ether: 7/3.
Skin tumours.-Skin tumours in the
treated area were recorded by visual inspec-
tion. The week of skin tumour was taken as
the week it was first observed on the living
mouse, whether or not it later regressed or
became malignant.
Histological preparations were examined
for all skin tumours in the treated area, and
the criterion of malignancy was penetration
ofthe muscle fibresofthepanniculuscarnosus.
Mice satisfying this criterion were said to
have an infiltrating skin carcinoma, and the
week ofinfiltrating skin carcinoma was taken
as the week of death ofthe animal.
In non-life-time experiments some extra
skin tumours and infiltrating skin carcinomas
were recorded at the week of termination, in
the first case because a special search was
carried out just before the mice were killed,
and in the second case because microscopy
revealed carcinomas which would otherwise
not have been found until a later date. In
order to avoid bias, these results were
ignored, and the experiment effectively
considered only up to the week before
termination.
Statistical methods
Weibull risk parameter (WRP).-Sepa-
rate analyses were carried out for skin-
tumour-bearing animals (TBA) and infiltra-
ting skin carcinomas (CBA). The response in
each treatment group was measured by the
" Weibull risk parameter " (WRP). The
definition of this parameter, the method of
calculation of it that was used, and justifica-
tions for its validity as a tumour index are
given in the Statistical Appendix. The
parameter measures relative incidence in the
sense that, at any instant of time, a tumour-
free mouse in a treatment with WRP of b1
has bl/b2 times the probability of getting a
tumour than has a tumour-free mouse in a
treatment with parameter b2. Use of the
WRP enables a proper comparison of the
carcinogenic effect of each treatment to be
made, unbiassed by any systematic differ-
ences in non-tumour mortality between
groups.
Tumorigenic ratio (TR).-The relative
activity, on a weight-for-weight basis, of
particular pairs of fractions tested (or of a
fraction and SWS) was measured by the
" tumorigenic ratio " (TR). The TR is
the inverse of the ratio of doses of the 2
fractions required to produce the same
response. For example a TR of 0-83
for the ratio of G to SWS implies that 83 mg
ofSWS is estimated to yield the same tumour
response as 100 mg (equivalent dose) of G.
Ifthe tumour-producing components of SWS
act independently, this value of0-83 can also
be taken to mean that 83% of these com-
ponents lie in fraction G. The method of
calculation of TR and the justification for its
use are given in the Statistical Appendix.
RESULTS
The results from the series of experi-
ments are summarized in Tables II-VIII.
Each table is laid out similarly, giving,
for each treatment group, details of
treatment, numbers ofanimals, percentage
TBA and CBA, and for each type of
response, the value of the index WRP.
It also gives for each relevant comparison,
the value of the TR with 95% con-
fidence limits.
Fractionation Scheme 1 (Fig. 1)
Stage 1 (Table II ).-The results con-
firmed earlier work (Whitehead and
Rothwell, 1969) which showed that
virtually all the active materials of whole
smoke condensate leading to the produc-
tion of skin tumours and the further
development of infiltrating carcinoma
are insoluble in water and can be con-
centrated into Fraction C.
Stage 2 (Table III ).-The' cyclo-
hexane-soluble material (Fraction G)
prepared by the distribution of Fraction
C between aqueous methanol and cyclo-
hexane, has been shown to retain on
average about 70% of the tumorigenic
material expressed in terms of both TBA
and CBA. This result holds for 3 dif-
ferent standard flue-cured cigarettes tested
over a period of years, and is not
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TABLE II.-Skin Tumour and Carcinoma Production of Whole Smoke Condensate (SWS)
and Fraction Cfrom Standard Flue-cured Cigarettes (T 29)
Animals with infiltrating
Dose Animals with skin tumours skin carcinoma
equiv. No. of ,_ _A_,_A_A
Expt. Treatment (mg/wk) animals % WRP % WRP
5 T29 SWS 300 198 43-4 3-09 15-2 4-78
C 300 102 52-9 3-13 23-5 5-29
C 600 102 58-8 5-95 19-6 7-61
TR* C/SWS 0*89 (0*73-1*10) 0*81 (0*62-1*05)
(Note: For this Table and Tables III to VIII the standard error of WRP can be computed from the
formula s.e. WEP = WRP/Vs where s = no. of animals with tumour (or carcinoma).)
* TR: Tumorigenic Ratio.
TABLE III.-Skin Tumour and Carcinoma Production of Whole Smoke Condensate (SWS)
and Fraction Gfrom Standard Flue-cured Cigarettes (T 4, T 29, T 44)
Expt. Treatment
2 T4 SWS
G
4 T29 SWS
G
G
5 T29 SWS
G
G
6 T29 SWS
G
G
6 T44 SWS
G
G
Dose
equiv. No. of
(mg/wk) animals
300 198
300 198
TR G/SWS
300 198
300 105
600 105
TR G/SWS
300 198
300 102
600 102
TR G/SWS
300 51
300 99
600 99
TR G/SWS
300 51
300 99
600 99
TR G/SWS
Animals with skin tumours
A
% VWRP
40 9 3*17
44.9 2 44
0 83 (0 66-1 03)
46 0 3*13 39 0 1 71
57-1 5 11
0 69 (0-56-0 84)
43 4 3 09
52 9 2 36
52 9 3 88
0 69 (0.56-0 85)
49 0 4 04
576 2 44
76 8 5.35
0 65 (0 47-0 88)
686 7-05
55 6 2 80
80 8 8 02
0 53 ( 400 -70)
Animals with infiltrating
skin carcinomas
% WRP
13 6 4 72
17 7 3 78
0*88 (0.66-1.17)
13 6 4-08
8 6 1*44
25 7 8 14
0 68 (0 51-0 90)
15 2 4 78
14*7 2 29
20 6 6 74
0 63 (0 48-0 83)
21 6 6 40
16 2 2 08
39 4 9 44
0 59 (0 41-0 85)
27 5 9 06
152 229
45 5 13 03
0 57 (0 41-0-78)
materially affected by the type of mouse
used.
Stage 3 (Table IV ).-The results
showed that, if Fraction G is distributed
between cyclohexane and dimethyl
sulphoxide (DMSO), the material
recovered from the DMSO (Fraction L(G)
representing 7 5% w/w of the original
whole smoke condensate) contains
slightly more activity than Fraction G in
the production of both tumours and
carcinomas. The material retained in the
cyclohexane, Fraction K(G), proved to
be of low carcinogenicity. The test on
the recombined fractions K(G) + L(G)
showed no significant reduction in activity
below the original Fraction G.
Fractionation Scheme 2 (Fig. 2)
Stage 3 (Table V ).-The material
extracted from Fraction G with a formic
acid solution of caffeine, Fraction
(R + P)G, was shown to have virtually
the same activity as Fraction G, both for
TBA and CBA. If the separation is
carried out in two stages, to produce
Fractions R(G) and P(SG), some small
loss of activity may occur, as indicated in
the results of the tests using the re-
combined material R(G) + P(SG), though
no individual TR was significantly less
than unity. The efficiency of the
separation procedure for extracting the
tumour-producing substances of smoke
condensate into Fraction (R + P)G or
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TABLE IV.-Skin Tumour and CarcinomaProduction ofFractions G, K(G) and L(G) from
Standard Flue-cured Cigarettes (T 29)
Animals with infiltrating
Expt. Treatmer
7 T29 G
G
K(G)
L(G)
L(G)
K(G)
K(G)
Dose
equiv. No. of
it (mg/wk) animals
300 117
600 117
600 198
300 105
600 105
+ L(G) 300 105
+ L(G) 600 105
TR K(G)/G
TR L(G)/G
TR K(G) + L(G)/G
Animals with skin tumours skin carcinomas
0 A
% WRP
53 8 2 20
62 4 3 80
10-1 0 23
57 1 2 63
70 5 5 36
47 6 1 76
58 1 3 32
0-12 (0-08-0-17)
1.22 (1.03-1.46)
0 88 (0 73-1 06)
% WRP
14*5 2 20
23 9 5.31
25 026
26 7 4.47
32 4 9 22
13 3 1 61
238 5-57
0-17 (0-10-029)
1.42 (1.15-1 78)
0 96 (0 75-1 22)
TABLE V.-Skin Tumour and Carcinoma Production ofFractions C, and (R + P)(G ana
Recombined Fraction R(G) + P(SG) from Standard Flue-cured Cigarettes (T29,
T 44, T 57)
Expt. Treatment
7 T29 G
G
(R + P)G
(R + P)G
R(G) + P(
R(G) + P(
9* T44 G
R(G)
10 T57 G
G
(R + P)G
(R + P)G
Dose
equiv. No. of
(mg/wk) animals
300 117
600 117
300 105
600 105
(SG) 300 105
(SG) 600 105
TR (R + P)G/G
TR R(G) + P(SG)/(
600 105
(SG) 600 105
TR R(G) + P(SG)/C
300 51
600 75
300 51
600 51
TR (R + P)G/G
* Surviving animals killed at Week 80.
Animals with skin tumours
% WRP
53 8 2 20
62 4 3 80
36 2 1 13
81-0 5 08
44 8 1 46
70 5 3 72
0 94 (0.79-1.13)
0 88 (0 73-1-05)
67 6 5 29
72 4 4 32
0 86 (0-68-1 09)
37 3 1 63
61 3 5 57
51-0 2 47
74 5 5 03
1-06 (0-82-1-36)
Animals with infiltrating
skin carcinomas
% WRP
14 5 2 20
23 9 5 31
15 2 1 87
40 0 9 36
7 6 0 97
305 5.37
1-20 (0-97-1-50)
0-88 (0 69-1.12)
22 9 10 63
23 8 7 82
0 84 (0 61-1.15)
13 7 2 35
353 664
17 6 3 24
31 4 7 42
1-05 (0-77-1-43)
TABLE VI.-Skin Tumour and Carcinoma Production ofFractions G and R(G) + P(SG)
from Standard Flue-cured Cigarettes (T 44), Cigars (C 3) and Flue-cured Cigarettes
Treated with 3% w/wSodium Nitrate (T 56)
Dose Animals with skin tumours
equiv. No. of A
Expt. Treatment (mg!wk) animals O WRP
9 T56 G 600 105 42 9 1 84
T44* G per per 67 6 5 29
C3* G group group 86 7 16 93
T56 R(G) + P(SG) 41 9 1 76
T44* R(G) + P(SG) 72 4 4 32
C3* R(G) + P(SG) 82 9 8 99
rT 56 0 97 (0-71-1.31)
TR R(G) + P(SG)/G i T 44 0 86 (0 68-1 09)
LC 3 0 63 (0 50-0 78)
TR C 3/T 44 (G 2 34 (1 85-2 99) R(G)+P(SG) 10 71 (1:36-216)
TR T56/T44 G 0.46 (0 35-0 60) R(G)+P(SG) 0-52 (0-39-0 68)
* Surviving animals killed at Week 80.
Animals with infiltrating
skin carcinomas
% WRP
7 6 2 07
22 9 10 63
48 6 46 97
14 3 3 97
23 8 7 82
39 0 22 70
1-44 (0 89-2 35)
0 84 (0 61-1 15)
0 67 (0.52-0 84)
2 29 (1 73-3 12)
181 (1 37-2 45)
0 40 (0-47-0 58)
0 68 (0 47-0 98)
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combined fractions R(G) + P(SG) is main-
tained whether different blends of flue-
cured cigarettes (T29, T44 and T57) are
used (Table V) or flue-cured cigarettes
treated with sodium nitrate (Table VI-
T56). The loss of activity in the prepara-
tion of R(G) + P(SG) from Fraction G is
statistically significant when condensate
from small cigars is used (Table VI).
The results oftests given in Tables VII
and VIII show that whole smoke conden-
sate from flue-cured cigarettes treated
with sodium nitrate is about half as active
in the production of tumours and car-
cinoma as condensate from untreated
cigarettes. Condensate from small
cigars, on the other hand, is over 50%
more active than standard cigarette smoke
condensate. A similar difference in
activity of Fraction G, or Fraction
R(G) + P(SG), obtained from the
smoke of these three products is also
demonstrated in Table VI.
DISCUSSION
A consideration of all the results
suggests that either of the separation
sequences:
SWS-*C--+G--*L(G)
or
SWS-4C--4G-*(R + P)G or R(G) + P(SG)
successfully concentrate a high proportion
of the tumour- and carcinoma-producing
substances of whole smoke condensate
-into fractions representing progressively
lower percentages by weight of the
original smoke material. Only small
tumorigenic activity could be detected in
fractions other than the above. Thus,
although the final fraction (R + P)LG
has not been tested, it seems likelv that a
combinationofthetwoseparationschemes,
using the sequence:
SWS--C--G---L(G)-*(R + P)LG
would achieve a concentration of the
carcinogenic material ofsmoke condensate
into a fraction representing under 2% by
weight of the original condensate.
Mouse skin bioassay of the sub-
fractions separately at each stage showed
an active fraction and a fraction with
little or no tumorigenic activity. Also,
the checks on the activity of the re-
combined fractions demonstrate that any
reduction in tumorigenicity of the active
fraction is due to mechanical losses
rather than to a separation of co-carcino-
gens into the fraction giving no tumours
when tested alone.
Whitehead and Lee (unpub.) show
in a separate paper that Stage 4 of
Fractionation Scheme 2a (Fig. 2) on
Fraction (R + P)G produces two fractions
R(G) and P(G), and that these fractions
contain materials of different carcinogenic
type. Assuming a multistage hypo-
thesis for carcinogenesis (Armitage and
Doll, 1954), the best fitting model to the
results of these mouse skin tests was one
in whch both fractions affected one stage
of the carcinogenic process and fraction
P(G) also affected another stage but to a
lesser degree. This result would be
consistent with the activity of Fraction P
TABLE VII.-Skin Tumour and Carcinoma Production of Whole Smoke Condensate (SWS)
from Standard Flue-cured Cigarettes (T 24) and Flue-cured Cigarettes Treated with
3% w/w Sodium Nitrate (T 22).
Dose No. of
Expt*. Treatment (mg/wk) animals
3 T24 SWS 108 168
180 per
300 group
T22 SWS 108
180
300
TR T 22/T 24
* SurvivinIg animals killed at week 93.
Animals with skin tumours
% WRP
17 9 0 66
22 6 1 34
36 9 2 19
5 4 0 16
13 1 0-50
17 3 0 60
0 41 (O 32-0 52)
Animals with infiltrating
skin carcinomas
, ~ ~ ~~AA
% WRP
3 0 0-62
3 0 1-04
6 5 1.91
0 6 0.10
1 2 0 27
3 6 0 68
0.50 (0 31-0 77)
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TABLEVJIII.-Skin Tumour and CarcinomaProduction of WholeSmoke Condensate (SWS)
from Standard Flue-cured Cigarettes (T 4, T 44) and Small Cigars (C 1, C 3)
Dose No. of
Expt. Treatment (mg/wk-) animals
1 T4 SWS 75 144
150 144
300 144
Cl SWS 37*5 144
75 144
150 144
TR C 1/T 4
8 T44* SWS 108 114
180 114
300 114
C3t SWS 65 120
108 120
180 120
TR C 3/T 44
* Surviving animals killed at Week 60.
t Surviving animals killed at Week 56.
being due to complete carcinogens (i.e.
PAH) with that of Fraction R being due
to small amounts of initiating substances
boosted substantially by co-carcinogens.
The tests described in this paper have
demonstrated that all the mouse skin
carcinogens of whole smoke condensate
can be substantially concentrated into
Fraction (R + P)G, irrespective of the
type of condensate used. However,
a further separation of these sub-
fractions is needed to explain differ-
ences in activity between different
condensates. The testing of Fractions R
and P from condensate from cigars,
standard flue-cured cigarettes and nitrate-
treated flue-cured cigarettes suggests that
the difference in activity of their conden-
sates, and of their fractions (R + P)G,
is due to the presence of different pro-
portions of the two types of incomplete
carcinogen.
The conclusions obtained in this paper
have been based on fitting to all 55
treatment groups a distribution of time to
tumour that is identical apart from one
parameter, the WRP. Although, as
shown in the Statistical Appendix, there
is evidence that this fit is significantly
imperfect, it is in practice extremely good
for such a large amount of data. This
finding, anid the fact that all tumorigenic
ratios have been based on comparisons
Animals with skin ttumours ,v.~~~~~~~
0
6 -3
27 -8
34 0
6-3
20 1
43-1
1-73 (1-41-
6-1
27 -2
38-6
2 5
25-8
50 8
1-90 (1-53-
WRP
0 19
1 -33
1-81
0 18
0 57
2 06
-2-12)
0-61
3.37
5-64
0 25
3*58
8-11
-2 ,36)
Animals with infiltratinig
skin carcinomas
0 0
6 -3
13 -2
0 7
6-9
12 -5
1 -69
0 0
4-4
2-6
0.0
2 -5
10-8
2-571
WRP
0 00
1 -47
2-99
0-10
0-75
2 29
(1-25-2-25)
0 00
10 21
6 -22
0*00
0 69
2 90
(1-60-4-18)
within one experiment, helps to answer
any doubts that may exist in making
overall conclusions from a series of
experiments carried out at different times,
and involving more than one animal
supplier. Untreated and positive (3,4-
benzo(a)pyrene-treated) controls were
in fact run for each experiment, but their
results were not used here as, since our
analysis would have been unaffected by
any factor systematically increasing (or
decreasing) the tumour response in all
groups in a particular experiment, they
could not have affected our conclusions.
Our conclusions are also based on the
assumption of a common dose response
relationship for all treatments, with the
logarithm of WRP linearly related to the
logarithm of dose. Davies, Lee and
Rothwell (1974) studied the dose response
of SWS on Carworth mice at 7 dose levels
ranging from 65 mg to 300 mg. They
concluded that there was a flattening off
in response between 180 mg and 300 mg,
and speculated that this might have been
due to the SWS killing off skin cells at
these dose levels. In our experiment,
various condensates were tested over a
range up to 300 mg, whereas the fractions
were tested at 300 and 600 mg. If the
higher dose levels of SWS had had this
toxic effect in our experiment and no dose
ofthefractionshad (whichmighthavebeen
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expected if the toxicity had been due to
nicotine), then the inclusion of the results
at high dose levels of SWS in the analysis
might have overestimated the true relative
tumorigenic effect of fraction to SWS.
Analysis given in the Statistical Appendix
shows that any bias caused by this high-
dose effect would be at worst only a slight
over-estimation of the tumorigenic ratios
G/SWS. Other ratios would not be
affected.
The authors wish to thank the
Tobacco Research Council for permission
to publish this paper, Dr R. F. Davies for
supervising all the mouse-skin painting
tests, Mr T. Smith for supervising the
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STATISTICAL APPENDIX
Definition and method of calculation of the
Weibull risk parameter (WRP )
Weibull distributions were fitted to the
databythe method ofPeto and Lee (1973).
In the Weibull distribution the probability
of an animal in group i, which does not
die from some other cause beforehand,
getting a tumour by time t can be expres-
sed as
G(tlk, w, bi) = 1 - exp ( bi(t -w)k)
The parameters k and w are indepen-
dent of the carcinogenic insult of the
treatment, which is measured by the
parameter bi. For data on skin tumours
the fitted (maximum likelihood) values of
k and w used were k = 3-046 and w
11 287: for data on infiltrating skin
carcinomas they were k = 5-369 and
w = 14*928. The Weibull risk parameter
(WRP) for a treatment group was taken
to be b, X 106 for skin tumours and
bi x 1011 for infiltrating skin carcinomas
The standard error of WRPi can be
calculated by the (asymptotic) formula:
s.e.WRPi = WRPi/,\/Si where Si is the
number of animals bearing tumours (or
carcinomas) in the group.
Goodness offit of Weibull distribution
a) Method.-For each treatment
group, the experimental period was sub-
divided into r 8-week periods and the
observednumberofTBAorCBAcompared
with that expected from the fitted Weibull
distributions. The expected value for
any period was calculated by scoring
b((t2 w)k - (t1 - w)k) for each
mouse surviving tumour-free until the
beginning of that period (t1), where t2
represents either the end of that period
ifthe mouse was still alive and tumourless
then or the time at which it died or got a
tumour if that occurred during the period.
These observeds and expecteds were then
summed over all the treatments to form
a single observed (0) and expected
(E) for each time period. The goodness
offitwasthentested bytaking (0 -E)2/
E as chi-squared on r - 3 degrees of
freedom.
b) Results.-The overall goodness of
fit to the whole data is given in Table IX.
c) Conclusions.-Although there isP. N. LEE, K. ROTHWELL AND J. K. WHITEHEAD
TABLE IX.-Overall Goodness ofFit in the 55 Treatment Groups
Period in weeks
1-32
33-40
41-48
49-56
57-64
65-72
73-80
81-88
89-96
97-end
x2 (7 d.f.)
p
Animals with skin tumours
Obs. Exp.
191 197 -02
335 285 -21
425 423-46
438 507 55
449 456-42
425 385-16
251 265-46
139 144- 86
72 64-46
26 21-40
25 -46
<0*001
Animals with infiltrating
skin carcinomas
Obs. Exp.
2 1-56
7 9-81
36 35 -27
93 85 30
132 129 -86
155 186-06
247 204 -61
134 143-65
92 101 -63
51 51-25
17 -20
<0*05
statistically significant evidence that the
overall shape of the time-to-tumour is not
perfectly Weibull it is clearly a very good
approximation. Despite a relative
increase in tumour incidence rate between
Weeks 32 and 96 by a factor of over 70
(TBA) and over 4000 (CBA) the observed
numbers of tumours stay relatively close
to those expected.
The goodness of fit to the Weibull
distributions was investigated further by
inspecting tabulations similar to Table IX
for both individual treatment groups and
wholeexperiments. Thelargest deviations
were in Exp. 5, where 98 TBA were
observed before Week 40, as against 50-2
expected, with a corresponding deficiency
of observed TBA later on (Weeks 49-64
O = 74, E - 111.8), and in Exp. 7, where
there was a marked deficiency in the first
32 weeks (O 11, E = 35 5). In general,
where these deviations occurred in an
experiment, they were present for all
treatment groups in that experiment, and
there was therefore no suggestion that
different k and w parameters should have
been fitted fordifferent types oftreatment.
Rather, the results suggest that something
atypical had happened in these experiment
at particular times, such as unusually poor
visual inspection for tumours, or perhaps
the presence of an infection. It was not
possible to determine the actual identity
of these occurrences but, as the principal
conclusions are based on comparison
within experiments rather than between
experiments, the results obtained are
unlikely to be severely biased by them.
Definition andjustification of the use of the
tumorigenic ratio (TR)
When assessing the relative activity
of two different fractions (or of the same
fractions from two different materials) it
is useful to be able to do this on a weight-
for-weight basis. However, for one to be
able to say validly that a given weight of
Fraction X produces an equivalent tumour
response to T x that weight ofFraction Y
(a TR of X/Y of T) for any given weight,
it is necessary that the shape of the
relationships between response and the
log dose for the two fractions compared be
parallel. Furthermore, it is convenient if
the response variable can be chosen so that
this relationship is linear. As there are
theoretical reasons for expecting b (and
therefore WRP) to be proportional to a
power ofdose (Peto and Lee, 1973), choice
of log b as a response measurement was
indicated, and Weibull mutiple regression
analysis (ibid.) was therefore carried out
to test the adequacy of the hypothesis
that the relationship between log b and log
dose was linear and parallel for every
treatment.
In this analysis, the parameters of the
following models were estimated:
I log bij =u
(No effect of treatment or dose)
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II log bij = + t*
(Effect of treatment only)
III log bj = + t* + q(log dose,)
(Effect of treatment and linear effect
of log dose)
IV log bj-
= + ti+ r;
(Effect of treatment and dose but no
interaction)
V log b*j v + 8ij
(Effect of treatment, dose and inter-
action between treatment and dose)
where the ti represent differences from tu
for the ith treatment and r, represent
differences from p for the jth dose level.
The effects of treatment, dose and treat-
ment + dose interaction were assessed by
likelihood ratio tests, and the results of
the analysis are summarized in Table X.
These results demonstrate that, though
there are statistically significant depar-
tures from the hypothesis (Model III), as
might be expected with such large amount
of data carried out at different times, it
explains a very great part of the
observed variation between the groups.
For TBA, 94% ofthevariation in response
at different dose levels can be explained by
the relationship b oc dose' 37, and for
CBA b cx dose1 79 explains 98% of this
variation.
Following further detailed inspection
of the fit to the linear log b-log dose
relationship (see next section) it was
concluded that the values ofTR presented
in Tables JI-VIII are a concise way of
comparing different treatments which
give, in virtually all cases, the very great
part of the information relevant to the
comparison.
The TR of two treatments i2 and i1 is
formally calculated by:
exp [(ti2 - ti1)/q]
using the results of Model III. The 95%
confidence limits of the tumorigenic ratio
T, were calculated by solving the quad-
ratic equation (in U)
V2 - (1.96)2Var V
whereV qU (t2 -t1), U log T and
the variances and covariances of q, t1 and
t2were obtained (asymptotically) from the
multiple regression equations.
Linearity of log dose-response relationship
As noted in the discussion there are a
priori reasons based on the findings of
Davies et al. (1974) why the linear relation-
ship assumed between log dose and log b
(or log WRP) might not hold at the
highest dose levels tested. The detailed
results of the multiple regression analysis
were therefore examined to see where
departures from the assumption occurred.
The main misfit occurred in SWS
(C3) (see Table VIII) where the dose
response was relatively steeper than that
for other materials. The response at
65 mg was particularly low compared
with that expected. The dose response
for (R + P)G (T29) (see Table V) was also
steeper that expected. For CBA, the
main misfit was for C (T29) (see Table II)
where the dose response was shallower
than expected. However there was no
TABLE X.-Results of Weibull Multiple Regression Analyses
Variables tested
Treatments
Linear effect of log dose
(corrected for treatments)
Non-linear effect of log dose
(corrected for treatments and
linear effect of log dose)
Treatment x log dose interaction
(corrected for treatments and
log dose)
Total
Degrees
Models of
compared freedom
Iv. II 30
Skin tumours
x2 p
1579-28 <0 001
II v. III 1 488-47 <0-001
III v. IV 6 32-58 <0-001
Infiltrating skin
carcinomas
x2 p
805-18 <0001
234-23 <0 001
5 15 N.S.
IVv. V 17 49 55 <0-001 38-32 <0-01
I v. V 54 214938 - 1082 -88
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marked evidence, as Davies' results would
suggest, of afall-off in response to SWS at
300 mg. The observed number ofTBA on
SWS at 300 mg (184) was somewhat
below expectation (202 9), while those for
fractions at 300 mg was somewhat above
(0 = 564,E; 534.8). Whilethisisinthe
direction that Davies' results predicted,
the magnitude of this difference is small
and not statistically significant.
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